Document is current
Any future updates will be listed below
-
Authors
Lopdell, Thomas J. http://orcid.org/0000-0002-7684-4870
Trevarton, Alexander J.
Moody, Janelle
Prowse-Wilkins, Claire
Knowles, Sarah
Tiplady, Kathryn
Chamberlain, Amanda J.
Goddard, Michael E.
Spelman, Richard J.
Lehnert, Klaus
Snell, Russell G.
Davis, Stephen R.
Littlejohn, Mathew D.
-
Funding
Funding for this research was provided by:
Ministry for Business Innovation and Employment (LICX1802)
- License Information
-
More Information
Article History
Received: 10 December 2023
Accepted: 12 March 2024
First Online: 28 March 2024
Declarations
:
: All animal experiments were conducted in strict accordance with the rules and guidelines outlined in the New Zealand Animal Welfare Act 1999. For the mammary tissue RNA sequencing biopsy experiment (for RNA-seq, ChIP-seq, and ATAC-seq), samples were obtained in accordance with protocols approved by the Ruakura Animal Ethics Committee, Hamilton, New Zealand (approval AEC 12845). These cows were situated on a research farm and permission was sought and obtained to biopsy mammary tissue from the owner of these animals (AgResearch, NZ). No animals were sacrificed for this study. For data collected during the Friesian-Jersey crossbreeding trial, milk samples were collected by subsampling during industry-standard milk collections. Ethics approval for all sample collection procedures was granted by the Ruakura Animal Ethics Committee. No animals were sacrificed during this study.
: Not applicable.
: TJL, KT, RJS, SRD, BLH, and MDL are employees of Livestock Improvement Corporation, a commercial provider of bovine germplasm. The other authors declare that they have no competing interests.
